Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma

Abstract Background Neuroendocrine prostate cancer (NEPC) may be rising in prevalence as patients with advanced prostate cancer potentially develop resistance to contemporary anti-androgen treatment through a neuroendocrine phenotype. While prior studies comparing NEPC and prostatic adenocarcinoma h...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Harrison K. Tsai, Jonathan Lehrer, Mohammed Alshalalfa, Nicholas Erho, Elai Davicioni, Tamara L. Lotan
Format: Artigo
Jezik:Inglês
Izdano: BMC 2017-11-01
Serija:BMC Cancer
Teme:
Neuroendocrine prostate cancer
Small cell carcinoma
Mixed prostatic adenocarcinoma
FFPE
Gene signature
Meta-analysis
Online pristup:http://link.springer.com/article/10.1186/s12885-017-3729-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items